Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All Speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Programme
WED 23 OCT
THU 24 OCT
FRI 25 OCT
WED 23 OCT
THU 24 OCT
FRI 25 OCT
Apply
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
09:00
Cannabis and causality — using multiple methods to unpick links between cannabis and neurobiology, cognition and mental health
09:00
to
10:30
Futures zone 3 (F3)
Suzanne Gage
Valentina Lorenzetti
Plenary II
Learning from the past to meet the challenges of the future
09:00
to
10:30
Main stage
Eilish Gilvarry
E-posters — day 2
09:00
to
19:30
e-poster terminals
10:30
Coffee break
10:30
to
10:50
NETWORKING ZONE
10:50
Towards a consensus approach to opioid substitution treatment outcomes and how they are monitored
10:50
to
12:20
Networking zone 1 (N1)
Lucas Wiessing
Methods and approaches to inform drug policy and practice
10:50
to
12:20
Networking zone 4 (N4)
Márya Hynes
The European Mosaic: prescription drug misuse across borders
10:50
to
12:20
Central square 1 (C1)
Richard Dart
Provision, available evidence and gaps
Drug-related interventions in European prisons
10:50
to
12:20
Insights zone 3 (I3)
Linda Montanari
Carina Ferreira Borges
Individually-tailored support and education for safer injection
10:50
to
12:20
Networking zone 2 (N2)
Carine Magen
Results from ATTUNE
Understanding pathways to stimulant use: a mixed methods examination of the individual, social and cultural factors shaping illicit stimulant use across Europe
10:50
to
12:20
Central square 2 (C2)
Marcus-Sebastian Martens
Understanding behaviours, risks and harms
10:50
to
12:20
Networking zone 3 (N3)
Xavier Majó
Providing an international focal point for access to research, training, institutional engagement and credentialing for field-based impact
Building a professional workforce for drug demand reduction
10:50
to
12:20
Insights zone 4 (I4)
Joanna Travis-Roberts
Lancet review series: Using evidence to better respond to drug problems - a call for action
10:50
to
12:20
Main stage
Pam Das
Candidates of behavioural addictions
10:50
to
12:20
Insights zone 2 (I2)
Naomi Fineberg
Stimulating the brain – FuturiZe thought leader round table
10:50
to
12:20
Futures zone 1 (F1)
Valentina Lorenzetti
Gender perspectives
10:50
to
12:20
Central square 3 (C3)
Anne Line Bretteville-Jensen
Monitoring trends and developments
10:50
to
12:20
Insights zone 1 (I1)
Larissa Maier
Funding opportunities for early career/experienced researchers
10:50
to
12:20
Futures zone 3 (F3)
Lindsey Hines
Alcohol perspectives and prevention - EUFAS poster session 2
10:50
to
12:20
Guided poster tours room
Linn Gjersing
12:20
Lunch
12:20
to
13:20
NETWORKING ZONE
Making better use of existing data through standardisation, methods and analysis - ISSDP poster session 2
12:20
to
13:20
Guided poster tours room
Rosalie Pacula
Abbvie sponsored session
HCV and addiction: a multidisciplinary approach
12:20
to
13:20
Insights zone 4 (I4)
12:40
online registration required
FuturiZe Technology tour on treatment and harm reduction
12:40
to
13:20
Futures zone 2 (F2)
Larissa Maier
Chrysanthi Blithikioti
13:20
Lessons from the past applied to the future
Post-marketing prescription drug mosaic surveillance
13:20
to
14:50
Main stage
Richard Dart
Regulating the low-THC cannabis market in Europe
13:20
to
14:50
Futures zone 1 (F1)
Davide Fortin
How to inform policy and decision makers about evidence-based prevention
13:20
to
14:50
Networking zone 2 (N2)
Matej Košir
Addicted to work: the use of cognitive enhancers in the workplace and the implications for occupational safety and health
13:20
to
14:50
Futures zone 2 (F2)
William Cockburn
Cannabis — risks and responses
13:20
to
14:50
Networking zone 4 (N4)
Jennifer Price
Injecting, risk and reducing harm
13:20
to
14:50
Networking zone 3 (N3)
Thomas Néfau
Alcohol: harms and policies
13:20
to
14:50
Futures zone 3 (F3)
Virginia Berridge
Evidence to guide future practice and policy
Enhancing hepatitis C treatment outcomes among people who use drugs
13:20
to
14:50
Insights zone 1 (I1)
Catharina Matheï
Adrian Dunlop
Focus on prescription drugs I
13:20
to
14:50
Insights zone 3 (I3)
Volker Auwärter
Infusing policy with evidence
13:20
to
14:50
Central square 3 (C3)
Lara Tavoschi
Opioid-related deaths: learning from pharmacology, laboratory-based studies and physical assessments
13:20
to
14:50
Central square 1 (C1)
Sir John Strang
Policy and treatment
13:20
to
14:50
Insights zone 2 (I2)
Matthew Young
Reducing drug-related deaths
13:20
to
14:50
Central square 2 (C2)
Catherine Comiskey
Treatment adherence
13:20
to
14:50
Insights zone 4 (I4)
Marta Torrens Melich
Using new technology and innovative methods to measure substance use and related harm
13:20
to
14:50
Networking zone 1 (N1)
Peter Reuter
The Reitox network poster session
13:20
to
14:50
Guided poster tours room
Nadine Berndt
14:50
Break
14:50
to
15:00
15:00
Global changes in cannabis products
15:00
to
16:30
Main stage
Tom Freeman
Wayne Hall
Current trends and future challenges
The cannabis policy kaleidoscope
15:00
to
16:30
Central square 2 (C2)
Nicola Singleton
Preclinical models and biomarkers
Exploring comorbidities in addiction
15:00
to
16:30
Insights zone 2 (I2)
Fernando Rodriguez de Fonseca
Future addictions EU multi-sector research project game jam
15:00
to
16:30
Futures zone 3 (F3)
Fleur Braddick
Silvia Matrai
Problematic usage of Internet: from assessment to intervention
15:00
to
16:30
Central square 1 (C1)
Ornella Corazza
Methodological challenges and comparative analyses in five European countries
Insight into the dynamics of substance use (research) in nightlife settings
15:00
to
16:30
Networking zone 1 (N1)
João Matias
Emerging issues in the management of conflicts of interest
15:00
to
16:30
Insights zone 1 (I1)
Niamh Fitzgerald
Take-home naloxone — its role in preventing opioid-related deaths in Europe
15:00
to
16:30
Insights zone 3 (I3)
Dagmar Hedrich
Sir John Strang
Treatment interventions
15:00
to
16:30
Networking zone 3 (N3)
Kari Grasaasen
Alcohol: comorbidity, risk and consequences
15:00
to
16:30
Central square 3 (C3)
Geert Dom
Drug markets
15:00
to
16:30
Insights zone 4 (I4)
Dirk Korf
Youth pathways
15:00
to
16:30
Networking zone 2 (N2)
Gregor Burkhart
Safer drugs? – FuturiZe thought leader round table
15:00
to
16:30
Futures zone 1 (F1)
Antoni Gual
Opioid-related deaths and other harms: current and emerging lessons - SSA poster session
15:00
to
16:30
Guided poster tours room
Sarah Welch
online registration required
Transcranial Magnetic Stimulation (TMS) – FuturiZe discussion and demo
15:00
to
16:30
Futures zone 2 (F2)
Graziella Madeo
Kasper Bredkær Sidenius
16:30
Coffee break
16:30
to
16:50
NETWORKING ZONE
16:50
Current and future challenges
Prison and drugs in Europe
16:50
to
18:20
Futures zone 3 (F3)
Linda Montanari
Liesbeth Vandam
New perspectives on cannabis use disorders and their treatment
16:50
to
18:20
Insights zone 4 (I4)
Tom Freeman
Valentina Lorenzetti
Pathways and societal responses in the UK, the Netherlands and Belgium (REC-PATH study)
Recovery from problematic drug use
16:50
to
18:20
Networking zone 2 (N2)
Wouter Vanderplasschen
Emerging drug trends in North Africa and Middle East
Focus on the EU borders
16:50
to
18:20
Insights zone 2 (I2)
Ioanna Yiasemi
Thomas Néfau
The Swedish ANDT-strategy
How to support the implementation of a comprehensive policy for alcohol, narcotics, doping, and tobacco from a public health perspective
16:50
to
18:20
Insights zone 1 (I1)
Linda Brännström
Results from a longitudinal UK general population cohort (ALSPAC)
Emerging health needs amongst adolescents who regularly use alcohol, cannabis or tobacco
16:50
to
18:20
Futures zone 2 (F2)
Jacqueline Vink
Trends and harms related to recreational drugs, prescription medicines and new psychoactive substances
European Drug Emergency Network Plus (Euro-DEN Plus)
16:50
to
18:20
Main stage
Nicola Singleton
Alcohol policies and preventions
16:50
to
18:20
Central square 1 (C1)
Antoni Gual
Alcohol: short communications on basic science, adolescence and comorbidity
16:50
to
18:20
Networking zone 3 (N3)
Jorgen G. Bramness
Factors influencing recovery
16:50
to
18:20
Insights zone 3 (I3)
Eilish Gilvarry
Gambling research
16:50
to
18:20
Networking zone 1 (N1)
Luke Clark
Issues for cannabis policy
16:50
to
18:20
Networking zone 4 (N4)
Krzysztof Krajewski
Methods and measurement of economic cost of substance use
16:50
to
18:20
Central square 3 (C3)
Rosalie Pacula
New methods
16:50
to
18:20
Central square 2 (C2)
André Noor
Striving towards the future elimination of Hep C among people who use drugs
16:50
to
18:20
Futures zone 1 (F1)
Eberhard Schatz
Perrine Roux
18:20
Break
18:20
to
18:30
18:30
An update of the evidence
Electronic cigarettes/vaping devices
18:30
to
19:30
Insights zone 1 (I1)
Leonie Brose
Lessons from the field
Measuring and monitoring drug policy for research, surveillance and practice
18:30
to
19:30
Networking zone 1 (N1)
Rosalie Pacula
Software-automated approach to monitoring online e-shops offering new psychoactive substances
18:30
to
19:30
Futures zone 3 (F3)
Vendula Belackova
Martin Pazitny
Opioids — current and emerging lessons
18:30
to
19:30
Networking zone 4 (N4)
Roumen Sedefov
Nightlife, festivals and other recreational settings
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Developing new prevention strategies to improve the situation of clients and employees of harm reduction services
18:30
to
19:30
Networking zone 2 (N2)
Gabi Becker
Quantifying addiction futures
Speculative addictions II
18:30
to
19:30
Futures zone 1 (F1)
Kari Lancaster
Tim Rhodes
Cannabis labelling and health warnings: use and impacts
18:30
to
19:30
Insights zone 4 (I4)
Hanan Abramovici
Challenges for harm reduction II
18:30
to
19:30
Insights zone 3 (I3)
Alessandro Pirona
Prevention science and measurement of demand reduction quality standards
18:30
to
19:30
Central square 1 (C1)
Nicola Singleton
Big debate
Industry friend or foe? Can industry contribute to better addiction science, policy, and actions?
18:30
to
19:30
Main stage
Florence Ranson
Henrietta Bowden-Jones OBE
Axel Klein
Paul Wallace
Niamh Fitzgerald
Sir Ian Gilmore
online registration required
Drug-checking technology – FuturiZe discussion and demo
18:30
to
19:30
Futures zone 2 (F2)
Pablo Barrio
Anton Luf
Daniel Martins
19:30
Networking buffet dinner
19:30
to
22:00
NETWORKING ZONE